Study Reveals Nonrelapse Causes of Deaths Among Cancer Patients on CAR-T Therapies

New York, NY – A recent study delving into the causes of death among cancer patients undergoing CAR-T therapies has revealed concerning findings regarding nonrelapse causes of mortality. The study, conducted by researchers in New York, focused on understanding why some patients on CAR-T therapies are succumbing to causes other than cancer. The study emphasized … Read more

Study Probes Nonrelapse Causes of Deaths Among Cancer Patients on CAR-T Therapies

Orlando, Florida – A recent study on cancer patients receiving CAR-T therapies has shed light on the causes of death beyond disease relapse. The research delves into the various factors contributing to mortality among individuals undergoing this innovative treatment approach. The findings of the study reveal that a significant number of deaths among cancer patients … Read more

FDA Committee Unanimously Supports CAR-T Therapies for Multiple Myeloma Despite Early Death Risks

Silver Spring, Maryland – The FDA’s Oncologic Drugs Advisory Committee voted in favor of supporting the approvals of CAR-T therapies as earlier lines of treatment for multiple myeloma. Johnson & Johnson, Legend Biotech, Bristol Myers Squibb, and 2seventyBio’s therapies were discussed during the meeting, with a focus on the risks associated with early deaths in … Read more